138
Participants
Start Date
April 30, 2018
Primary Completion Date
February 19, 2019
Study Completion Date
February 21, 2019
LPCN 1021
LPCN 1021 is gelatin capsule product provided as 112.5 mg testosterone undecanoate per capsule.
Manhattan Medical Research Practice PLLC, New York
AccuMed Research Associates, Garden City
Jacksonville Impotence Treatment Center, Jacksonville
Oviedo Medical Research, LLC, Oviedo
Neostart Corporation dba AGA Clinical Trials, Hialeah
Clinical Research Center of Florida, Pompano Beach
Clinical Research of South Florida, Coral Gables
South Florida Medical Research, Aventura
Alabama Clinical Therapeutics, Birmingham
Clinical Research Associates, Inc., Nashville
Central Kentucky Research Associates, Inc., Lexington
Aventiv Research, Inc., Columbus
Prestige Clinical Research, Franklin
Regional Urology, Shreveport
Granger Medical Clinic, West Valley City
Rainier Clinical Research Center, Renton
Lead Sponsor
Lipocine Inc.
INDUSTRY